Mutsuo Furihata

Title: Mutsuo Furihata: Innovator in Cancer Detection and Treatment

Introduction

Mutsuo Furihata is a notable inventor based in Kochi, Japan. He has made significant contributions to the field of medical technology, particularly in cancer detection and treatment. With a total of 2 patents, his work focuses on improving the accuracy and effectiveness of cancer diagnostics and therapies.

Latest Patents

Furihata's latest patents include a method for the detection of urothelial cancer. This innovative method provides a simple and highly accurate way to detect urothelial cancer by administering 5-aminolevulinic acid (ALA) or its derivatives to a test subject. The process involves collecting urine from the subject and detecting the presence or amount of fluorescence in the urine. Another significant patent is a treatment agent and/or prophylactic agent for the side effects of cancer drugs. This method involves administering a compound that can effectively treat or prevent side effects caused by anticancer agents.

Career Highlights

Throughout his career, Mutsuo Furihata has worked with various organizations, including Sbi Pharmaceuticals Co., Ltd. and Kochi University. His experience in these institutions has allowed him to develop and refine his innovative ideas in the medical field.

Collaborations

Furihata has collaborated with notable colleagues such as Keiji Inoue and Taro Shuin. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Mutsuo Furihata's contributions to cancer detection and treatment exemplify the impact of innovation in healthcare. His patents reflect a commitment to improving patient outcomes through advanced medical technologies.